‘When we program people’s cells to make things they’re not supposed to make, they can go haywire, they can mutate.’
A peer-reviewed study from Portugal revealed an incident of psoriatic arthritis in a woman just a month after taking the second dose of COVID-19 vaccine.
The
study, published in the Cureus journal on Dec. 18, detailed the potential negative effects of the COVID-19 vaccine on a 56-year-old woman who was under treatment for plaque psoriasis for 44 years.
Plaque
psoriasis is an autoimmune disease that produces thick patches on the skin, including the scalp. A month after the woman received a second shot of Pfizer’s mRNA COVID-19 vaccine in 2021, she began experiencing health complications.
The afflicted woman was eventually diagnosed with
psoriatic arthritis, a form of arthritis that affects individuals who have psoriasis. Arthritis is the
inflammation of the joints. The authors
noted that the COVID-19 vaccination “may have triggered severe and debilitating” psoriatic arthritis.
Though the
psoriatic flare in the woman “appeared” to be linked to the administration of a certain medication as part of her treatment, the authors stressed that “the effect of vaccination cannot be dismissed.”
They noted that “to date, reports from the literature support that the exacerbation or appearance of rheumatological diseases following COVID-19 vaccinations seem to have a good prognosis as they are still rare, short-lived, and respond well to steroids and other immunosuppressant agents.”
More studies on the topic are necessary to determine which individuals are at the greatest risk of experiencing a worsening of their rheumatological disease post-COVID-19 vaccination or infection, the authors stated.
“Amid the ongoing worldwide vaccination against SARS-CoV-2, clinicians need to be prepared to discuss the risks and benefits of vaccination, acknowledging that it may exacerbate immune disorders and planning for a close follow-up in terms of disease progression and treatment.”
The authors cited an October 2023 systematic
review of multiple studies that found 271 cases of rheumatic diseases from 39 nations following COVID-19 vaccination. These cases were reported between January 2021 and May 2023.
The review found that 50 percent of patients had developed rheumatic disease after the second dose of COVID-19 vaccine.
Disease Progression
In August 2021, the woman
came to the clinic operated by the study authors a month after she received the Pfizer vaccine. She complained about experiencing new migratory polyarthralgia during the previous three weeks.
Polyarthralgia is a
condition in which the patient experiences pain in multiple joints in the body.
She
reported inflammatory symptoms like redness, warmth, swelling, pain, and loss of function in the right knee joint that migrated to the left wrist, then to the right wrist, and eventually to the right Achilles tendon.
“She was suffering from severe debilitating pain,” said the report.
The woman was given medication and sent home. However, the condition progressed in the following month. Disease measurements indicated “high disease activity.”
In mid-September 2021, she was prescribed another medication and referred for consultation with a
rheumatologist—an expert specializing in inflammatory diseases like arthritis, muscle injuries, and tendon issues.
A
month later in October 2021, the woman was still suffering from complications, and another medication was added. In November 2021, her rheumatic disease worsened.
The dosage of a medication was increased, which resulted in improvement in the pain and joint inflammation. By the end of the month, the rheumatic disease became more stable. However, the skin condition worsened.
A clinical examination later on revealed extensive scaly plaques on the scalp, legs, arms, abdomen, and trunk. She was diagnosed with
psoriatic arthritis.
The experts changed her
therapy and prescribed calcium and vitamin D. In July 2022, the woman got infected with COVID-19 while experiencing an exacerbation of polyarthralgia simultaneously for two days.
Since then, until the submission of the study in November of this year, the woman has been on a monthly administration of secukinumab, a
drug for psoriatic arthritis.
The authors stated that they received no financial support from any organization for the work and that there were no other relationships or activities that could have influenced the study.
Vaccination and Autoimmune Diseases
Psoriasis is an
autoimmune disease. The body sees its own tissues as foreign invaders and attacks them.
In an
interview with the “American Thought Leaders” program, clinical pathologist Dr. Ryan Cole suggested that DNA contamination in some of the COVID-19 vaccines could result in autoimmune diseases.
Researchers have found Pfizer COVID-19 vaccine vials containing billions of residual DNA fragments. Dr. Cole pointed out that the smaller the fragment, the higher the likelihood that it can insert itself into a person’s DNA.
“Several of us are in some small communication groups, trying to figure out the long-term implications of this. But it does explain a lot of the really strange happenings in the human body that we’re seeing in terms of, you know, clots, auto-immune disease, cancers, etc.,” he said.
“Human cells are meant to make human proteins … Human cells were not meant to make foreign proteins. When we program people’s cells to make things they’re not supposed to make, they can go haywire, they can mutate, they can become a target, have ... our own immune system attacking ourselves.”
Speaking to The Epoch Times, internal medicine physician Dr. Keith Berkowitz
said that he found gut problems among post-vaccine patients. He has treated 200 COVID-19 vaccine-injured individuals.
Poor gut health is linked to a wide range of illnesses, including autoimmune diseases, cancer, dementia, and diabetes.
Dr. Berkowitz noted that many of his patients who had gut issues and overactive nervous systems also tested positive for autoantibodies, which signals potential autoimmune disease.
“Nerve pain, fatigue, muscle and joint issues are probably the most common issues [with these patients],” he said.
